Literature DB >> 18329945

Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.

Caroline A Owen1.   

Abstract

A number of proteinases are expressed on the surface of leukocytes including members of the serine, metallo-, and cysteine proteinase superfamilies. Some proteinases are anchored to the plasma membrane of leukocytes by a transmembrane domain or a glycosyl phosphatidyl inositol (GPI) anchor. Other proteinases bind with high affinity to classical receptors, or with lower affinity to integrins, proteoglycans, or other leukocyte surface molecules. Leukocyte surface levels of proteinases are regulated by: (1) cytokines, chemokines, bacterial products, and growth factors which stimulate synthesis and/or release of proteinases by cells; (2) the availability of surface binding sites for proteinases; and/or (3) internalization or shedding of surface-bound proteinases. The binding of proteinases to leukocyte surfaces serves many functions including: (1) concentrating the activity of proteinases to the immediate pericellular environment; (2) facilitating pro-enzyme activation; (3) increasing proteinase stability and retention in the extracellular space; (4) regulating leukocyte function by proteinases signaling through cell surface binding sites or other surface proteins; and (5) protecting proteinases from inhibition by extracellular proteinase inhibitors. There is strong evidence that membrane-associated proteinases on leukocytes play critical roles in wound healing, inflammation, extracellular matrix remodeling, fibrinolysis, and coagulation. This review will outline the biology of membrane-associated proteinases expressed by leukocytes and their roles in physiologic and pathologic processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329945      PMCID: PMC2425676          DOI: 10.1016/j.biocel.2008.01.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  270 in total

1.  Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion.

Authors:  D G Myles; L H Kimmel; C P Blobel; J M White; P Primakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

2.  A discrete subpopulation of human monocytes expresses a neutrophil-like proinflammatory (P) phenotype.

Authors:  C A Owen; M A Campbell; S S Boukedes; R A Stockley; E J Campbell
Journal:  Am J Physiol       Date:  1994-12

Review 3.  The role of thiol proteases in tissue injury and remodeling.

Authors:  H A Chapman; J S Munger; G P Shi
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

4.  Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.

Authors:  T H Bugge; M J Flick; C C Daugherty; J L Degen
Journal:  Genes Dev       Date:  1995-04-01       Impact factor: 11.361

5.  Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.

Authors:  A Y Strongin; I Collier; G Bannikov; B L Marmer; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

6.  The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation.

Authors:  J Cao; H Sato; T Takino; M Seiki
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

7.  Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface.

Authors:  D H Allen; P B Tracy
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

8.  Physiological consequences of loss of plasminogen activator gene function in mice.

Authors:  P Carmeliet; L Schoonjans; L Kieckens; B Ream; J Degen; R Bronson; R De Vos; J J van den Oord; D Collen; R C Mulligan
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

9.  Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.

Authors:  N Bangalore; J Travis
Journal:  Biol Chem Hoppe Seyler       Date:  1994-10

10.  TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.

Authors:  R Alon; L Cahalon; R Hershkoviz; D Elbaz; B Reizis; D Wallach; S K Akiyama; K M Yamada; O Lider
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

View more
  29 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.

Authors:  Joselyn Rojas-Quintero; Xiaoyun Wang; Jennifer Tipper; Patrick R Burkett; Joaquin Zuñiga; Amit R Ashtekar; Francesca Polverino; Amit Rout; Ilyas Yambayev; Carmen Hernández; Luis Jimenez; Gustavo Ramírez; Kevin S Harrod; Caroline A Owen
Journal:  JCI Insight       Date:  2018-12-20

3.  An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages.

Authors:  Kyung Ho Han; Rosana Gonzalez-Quintial; Yingjie Peng; Roberto Baccala; Argyrios N Theofilopoulos; Richard A Lerner
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

4.  ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury.

Authors:  Robin Roychaudhuri; Anja H Hergrueter; Francesca Polverino; Maria E Laucho-Contreras; Kushagra Gupta; Niels Borregaard; Caroline A Owen
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

Review 5.  Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Maria E Laucho-Contreras; Francesca Polverino; Yohannes Tesfaigzi; Aprile Pilon; Bartolome R Celli; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2016-02-11       Impact factor: 6.902

6.  Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.

Authors:  Kristopher R Genschmer; Derek W Russell; Charitharth Lal; Tomasz Szul; Preston E Bratcher; Brett D Noerager; Mojtaba Abdul Roda; Xin Xu; Gabriel Rezonzew; Liliana Viera; Brian S Dobosh; Camilla Margaroli; Tarek H Abdalla; Robert W King; Carmel M McNicholas; J Michael Wells; Mark T Dransfield; Rabindra Tirouvanziam; Amit Gaggar; J Edwin Blalock
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 7.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

8.  Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.

Authors:  Brice Korkmaz; Jérôme Jaillet; Marie-Lise Jourdan; Alexandre Gauthier; Francis Gauthier; Sylvie Attucci
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

9.  A sequence and structure based method to predict putative substrates, functions and regulatory networks of endo proteases.

Authors:  Prasanna Venkatraman; Satish Balakrishnan; Shashidhar Rao; Yogesh Hooda; Suyog Pol
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

Review 10.  ADAM8: a new therapeutic target for asthma.

Authors:  Martin D Knolle; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.